Search research articles
Contact Us
Filters
Showing results (31-40 of 194) with videos related to
Page
of 20
Sort By:
Statistics in Medicine
|
August 8, 2007
Clustering of significant genes in prognostic studies with microarrays: application to a clinical study for multiple myeloma
Shigeyuki Matsui, Takeharu Yamanaka, Bart Barlogie, et al.
Blood
|
January 10, 2008
High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone
Fenghuang Zhan, Bart Barlogie, George Mulligan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2008
Tumor cell gene expression changes following short-term in vivo exposure to single agent chemotherapeutics are related to survival in multiple myeloma
Bart Burington, Bart Barlogie, Fenghuang Zhan, et al.
Journal of Virology
|
August 1, 1995
Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels
D A Largaespada, J D Shaughnessy, N A Jenkins, et al.
The Onderstepoort Journal of Veterinary Research
|
June 1, 1980
Occurrence of Taenia solium in a Cape fur seal (Arctocephalus pusillus)
A S De Graaf, P D Shaughnessy, R M McCully, et al.
Leukemia
|
February 29, 2008
Making progress in treating multiple myeloma with total therapies: issue of complete remission and more
B Barlogie, F van Rhee, J D Shaughnessy, et al.
The Journal of Pediatrics
|
December 24, 1997
Development of systemic to pulmonary collateral arteries in premature infants
R D Shaughnessy, M D Reller, M J Rice, et al.
British Journal of Haematology
|
January 6, 2009
Immunoglobulin isotypes in multiple myeloma: laboratory correlates and prognostic implications in total therapy protocols
Bijay Nair, Sarah Waheed, Jackie Szymonifka, et al.
Seminars in Hematology
|
June 26, 2012
Proteasome inhibitors and bone disease
Ya-Wei Qiang, Christoph J Heuck, John D Shaughnessy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2012
Developing and validating continuous genomic signatures in randomized clinical trials for predictive medicine
Shigeyuki Matsui, Richard Simon, Pingping Qu, et al.
Page
of 20
Search research articles
Search
Showing results (31-40 of 194) with videos related to
Sort By:
Page
of 20
Statistics in Medicine
|
August 8, 2007
Clustering of significant genes in prognostic studies with microarrays: application to a clinical study for multiple myeloma
Shigeyuki Matsui, Takeharu Yamanaka, Bart Barlogie, et al.
Blood
|
January 10, 2008
High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone
Fenghuang Zhan, Bart Barlogie, George Mulligan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2008
Tumor cell gene expression changes following short-term in vivo exposure to single agent chemotherapeutics are related to survival in multiple myeloma
Bart Burington, Bart Barlogie, Fenghuang Zhan, et al.
Journal of Virology
|
August 1, 1995
Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels
D A Largaespada, J D Shaughnessy, N A Jenkins, et al.
The Onderstepoort Journal of Veterinary Research
|
June 1, 1980
Occurrence of Taenia solium in a Cape fur seal (Arctocephalus pusillus)
A S De Graaf, P D Shaughnessy, R M McCully, et al.
Leukemia
|
February 29, 2008
Making progress in treating multiple myeloma with total therapies: issue of complete remission and more
B Barlogie, F van Rhee, J D Shaughnessy, et al.
The Journal of Pediatrics
|
December 24, 1997
Development of systemic to pulmonary collateral arteries in premature infants
R D Shaughnessy, M D Reller, M J Rice, et al.
British Journal of Haematology
|
January 6, 2009
Immunoglobulin isotypes in multiple myeloma: laboratory correlates and prognostic implications in total therapy protocols
Bijay Nair, Sarah Waheed, Jackie Szymonifka, et al.
Seminars in Hematology
|
June 26, 2012
Proteasome inhibitors and bone disease
Ya-Wei Qiang, Christoph J Heuck, John D Shaughnessy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2012
Developing and validating continuous genomic signatures in randomized clinical trials for predictive medicine
Shigeyuki Matsui, Richard Simon, Pingping Qu, et al.
Page
of 20